CT contrast predicts pancreatic cancer treatment response to verteporfin-based photodynamic therapy

Author： Jermyn Michael   Davis Scott C   Dehghani Hamid   Huggett Matthew T   Hasan Tayyaba   Pereira Stephen P   Bown Stephen G   Pogue Brian W  

Publisher： IOP Publishing

ISSN： 0031-9155

Source： Physics in Medicine and Biology, Vol.59, Iss.8, 2014-04, pp. : 1911-1921

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pre‐treatment carbohydrate antigen 19‐9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer

By  

HPB, Vol. 17, Iss. 10, 2015-10 ,pp. : 942-952

John Wiley & Sons Inc

Access to resources Recommend Favorite

Photodynamic therapy as salvage treatment forrecurrent head and neck cancer

By Gangloff Pierre   Phulpin Bérengère   Cortese Sophie   Gallet Patrice   Bravetti Pierre   Mastronicola Romina   Guillemin François   Dolivet Gilles  

Médecine Buccale - Chirurgie Buccale, Vol. 18, Iss. 4, 2012-11 ,pp. : 325-331

Edp Sciences

Access to resources Recommend Favorite

Verteporfin photodynamic therapy and anti-angiogenic drugs: potential for combination therapy in exudative age-related macular degeneration

By Kaiser P. K.  

Current Medical Research and Opinion, Vol. 23, Iss. 3, 2007-03 ,pp. : 477-487

Informa Healthcare

Access to resources Recommend Favorite

Genetic Predictors of Response to PhotodynamicTherapy

By Parmeggiani Francesco  

Molecular Diagnosis & Therapy, Vol. 15, Iss. 4, 2011-08 ,pp. : 195-210

Adis International

Access to resources Recommend Favorite

Prognostic significance of DNA cytometry for adjuvant therapy response in pancreatic cancer

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 1, 2015-07 ,pp. : 66-71

John Wiley & Sons Inc

Access to resources Recommend Favorite